Business Standard

Wednesday, December 25, 2024 | 04:11 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Usha Martin board heeds NCLT directive, refrains from capital infusion

While status quo is to be maintained on shareholding pattern, firm allowed to raise debt

Usha Martin
Premium

Logo of Usha Martin. (Photo courtesy: Usha Martin)

Avishek Rakshit Kolkata
The Usha Martin board, in its meeting on Saturday, decided not to opt for fresh capital infusion in the company following the directives of the National Company Law Tribunal (NCLT). 
  
The board had earlier decided that the company’s promoters, Prashant Jhawar and Rajeev Jhawar would infuse Rs 45 crore each to help the company pay off debts and for other purposes.

However, on Thursday, the company’s ousted chairman Prashant Jhawar, who is also a promoter, board member Basant K Jhawar and other promoter shareholders had appealed to NCLT to stay the board meeting scheduled on Saturday.

Although the NCLT declined to

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in